QMB Raises $2 Million Seed Round

by Kay Aloha Villamor in November 13th, 2025

Quality Means Business (QMB), a Boston, MA-based AI-driven MedTech SaaS company, has raised $2 million in Seed funding. 

Investors

The round was led by The Boston Foundation’s Business Equity Investment Fund and CEI Ventures. 

Founded in 1915, The Boston Foundation is one of the nation’s largest and oldest community foundations, managing $1.9 billion in assets. It partners with nearly 1,000 donors to build a more prosperous and equitable Greater Boston region where justice and opportunity are extended to all. 

CEI Ventures, Inc. is an impact venture capital firm founded in 1994 that invests in companies driving social and environmental impact. Based in Maine, CEI Ventures is wholly owned by Coastal Enterprises, Inc. (CEI), a CDFI that has deployed more than $1.6 billion to grow businesses and strengthen communities. 

QMB Use of Funds 

The company will use the capital to expand engineering capabilities, strengthen data integrations, and advance its RegTech-as-Infrastructure™ pilots with MedTech manufacturers by late 2025. 

About Quality Means Business (QMB) 

Founded and led by Michel Moravia, Quality Means Business (QMB) provides an AI-native enterprise platform designed to unify design control, risk management, regulatory intelligence, and compliance scoring. Its flagship platform, QualiVerse®, is a regulatory intelligence engine that helps medical device innovators achieve compliance, accelerate product development, and scale safely to market. Headquartered in Boston, Massachusetts, QMB’s mission is to elevate human well-being by harnessing the power of AI to empower medical technology innovators to accelerate regulatory success. 

Funding Details 

Company: Quality Means Business (QMB, Inc.)

Raised: $2.0M

Round: Seed 

Funding Date: November 2025 

Lead Investors: The Boston Foundation’s Business Equity Investment Fund, CEI Ventures 

Additional Investors:  

Company Website: https://www.qmb.ai/  

Software Category: AI-Driven MedTech / Regulatory Intelligence SaaS 

Source: https://www.businesswire.com/news/home/20251112838343/en/

Your cart